Markus Teschner

720 total citations
50 papers, 580 citations indexed

About

Markus Teschner is a scholar working on Nephrology, Hematology and Clinical Biochemistry. According to data from OpenAlex, Markus Teschner has authored 50 papers receiving a total of 580 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Nephrology, 10 papers in Hematology and 9 papers in Clinical Biochemistry. Recurrent topics in Markus Teschner's work include Iron Metabolism and Disorders (9 papers), Chronic Kidney Disease and Diabetes (8 papers) and Metabolism and Genetic Disorders (7 papers). Markus Teschner is often cited by papers focused on Iron Metabolism and Disorders (9 papers), Chronic Kidney Disease and Diabetes (8 papers) and Metabolism and Genetic Disorders (7 papers). Markus Teschner collaborates with scholars based in Germany, United States and Poland. Markus Teschner's co-authors include A. Heidland, Roland M. Schaefer, R. M. Schaefer, Markus Kosch, Liliana Schaefer, Hong Ling, Udo Bahner, F Matzkies, Leszek Pączek and Ulrich E. Heidland and has published in prestigious journals such as Kidney International, Journal of the American Society of Nephrology and Diabetologia.

In The Last Decade

Markus Teschner

48 papers receiving 556 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Markus Teschner Germany 13 205 107 98 90 78 50 580
T. Malachi Israel 15 169 0.8× 203 1.9× 86 0.9× 98 1.1× 61 0.8× 33 739
N.D. Vaziri United States 14 210 1.0× 68 0.6× 158 1.6× 84 0.9× 45 0.6× 30 525
Farzad Ziai United States 13 253 1.2× 85 0.8× 110 1.1× 89 1.0× 38 0.5× 14 640
Makoto Suzuki Japan 16 105 0.5× 75 0.7× 84 0.9× 144 1.6× 70 0.9× 62 702
Akira Hishida Japan 14 369 1.8× 269 2.5× 48 0.5× 82 0.9× 47 0.6× 23 756
Terukuni Ideura Japan 19 384 1.9× 194 1.8× 99 1.0× 174 1.9× 98 1.3× 62 1.0k
Susan F Travis United States 11 97 0.5× 80 0.7× 94 1.0× 86 1.0× 203 2.6× 25 647
Hisaki Shimada Japan 11 278 1.4× 105 1.0× 77 0.8× 85 0.9× 28 0.4× 19 471
Y. Berland France 7 377 1.8× 298 2.8× 79 0.8× 75 0.8× 128 1.6× 8 776
J. Michael United Kingdom 15 196 1.0× 116 1.1× 36 0.4× 76 0.8× 106 1.4× 27 699

Countries citing papers authored by Markus Teschner

Since Specialization
Citations

This map shows the geographic impact of Markus Teschner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Teschner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Teschner more than expected).

Fields of papers citing papers by Markus Teschner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Teschner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Teschner. The network helps show where Markus Teschner may publish in the future.

Co-authorship network of co-authors of Markus Teschner

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Teschner. A scholar is included among the top collaborators of Markus Teschner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Teschner. Markus Teschner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Scheppach, W, Markus Teschner, T. Kirchner, et al.. (2008). Akute Pankreatitis und Magenwandnekrose durch Cholesterinembolie. DMW - Deutsche Medizinische Wochenschrift. 118(01/02). 13–18. 4 indexed citations
2.
Teschner, Markus, A. Heidland, André Klassen, Katarı́na Šebeková, & Udo Bahner. (2004). Georg Ganter — a pioneer of peritoneal dialysis and his tragic academic demise at the hand of the Nazi regime. Journal of Nephrology. 17(3). 457–460. 11 indexed citations
3.
Händel, M., et al.. (2001). Increased interleukin-6 in collected drainage blood after total knee arthroplasty: An association with febrile reactions during retransfusion. Acta Orthopaedica Scandinavica. 72(3). 270–272. 29 indexed citations
5.
Matzkies, F, et al.. (1999). Efficiency of 1-Year Treatment with Fluvastatin in Hyperlipidemic Patients with Nephrotic Syndrome. American Journal of Nephrology. 19(4). 492–494. 12 indexed citations
6.
Huang, Shaoming, Roland M. Schaefer, Leszek Pączek, et al.. (1999). Suppressed Activities of Cathepsins and Metalloproteinases in the Chronic Model of Puromycin Aminonucleoside Nephrosis. Kidney & Blood Pressure Research. 22(3). 121–127. 11 indexed citations
7.
Ling, Hong, Spyridon Vamvakas, Liliana Schaefer, et al.. (1995). Insulin-Like Growth Factor I Induced Reduction in Cysteine Proteinase Activity in Freshly Isolated Proximal Tubule Cells of the Rat. ˜The œNephron journals/Nephron journals. 69(1). 83–85. 4 indexed citations
8.
Teschner, Markus, et al.. (1994). Effect of Metabolic Acidosis on Tubular Proteinase Activity. ˜The œNephron journals/Nephron journals. 66(3). 344–347. 6 indexed citations
9.
Schaefer, Liliana, R. M. Schaefer, Hong Ling, Markus Teschner, & A. Heidland. (1994). Renal proteinases and kidney hypertrophy in experimental diabetes. Diabetologia. 37(6). 567–571. 43 indexed citations
10.
Pączek, Leszek, J. Pazik, Markus Teschner, et al.. (1994). Human chronic kidney allograft rejection is accompanied by increased intraglomerular cathepsin B and L activity. Transplant International. 7(s1). 311–313. 2 indexed citations
11.
Pączek, Leszek, et al.. (1992). Intraglomerular Proteinase Activity in Adriamycin-lnduced Nephropathy. ˜The œNephron journals/Nephron journals. 60(1). 81–86. 20 indexed citations
12.
Pączek, Leszek, Markus Teschner, R. M. Schaefer, et al.. (1991). Proteinase Activity in Isolated Glomeruli of Goldblatt Hypertensive Rats. Clinical and Experimental Hypertension Part A Theory and Practice. 13(3). 339–356. 4 indexed citations
13.
Pączek, Leszek, Markus Teschner, R. M. Schaefer, & A. Heidland. (1991). Intraglomerular fibronectin accumulation and degradation in obese Zucker rats. Diabetologia. 34(11). 786–789. 9 indexed citations
14.
Teschner, Markus, Leszek Pączek, R. M. Schaefer, & A. Heidland. (1991). Obese zucker rat: Potential role of intraglomerular proteolytic enzymes in the development of glomerulosclerosis. Research in Experimental Medicine. 191(1). 129–135. 5 indexed citations
15.
Schaefer, Roland M., et al.. (1989). Catabolic Effects of Ethanol in Chronically Uremic Rats. ˜The œNephron journals/Nephron journals. 51(1). 67–72. 3 indexed citations
16.
Teschner, Markus & A. Heidland. (1989). Hypercatabolism in Acute Renal Failure - Mechanisms and Therapeutical Approaches. Blood Purification. 7(1). 16–27. 5 indexed citations
17.
Massry, Shaul G., et al.. (1989). Effect of parathyroid hormone on elastase release from human polymorphonuclear leucocytes. Kidney International. 36(5). 883–890. 27 indexed citations
18.
Teschner, Markus, et al.. (1989). Independence of enhanced protein catabolism from glucocorticoids in chronically uremic rats. Research in Experimental Medicine. 189(5). 339–345. 2 indexed citations
19.
Teschner, Markus, et al.. (1988). Eglin C Fails to Reduce Catabolism in Acutely Uremic Rats. Advances in experimental medicine and biology. 240. 331–337. 1 indexed citations
20.
Schaefer, Roland M., et al.. (1987). Evidence for Reduced Catabolism by the Antiglucocorticoid RU 38486 in Acutely Uremic Rats. American Journal of Nephrology. 7(2). 127–131. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026